Usama Dar appointed as chief product and technology officer at CluePoints
April 2, 2025Research and Development Pharmacy, clinical trial analysis, cluepoints, pharma, research and development
CluePoints has appointed Usama Dar as its new chief product and technology officer, effective 1 April 2025. This follows Dar’s …
Dupixent approved as first biologic medicine in Japan for COPD patients
April 2, 2025Research and Development COPD, Chronic Diseases, Regeneron, Sanofi, biotech, respiratory disease
The Ministry of Health, Labour and Welfare in Japan has authorised marketing and manufacturing of Dupixent (dupilumab) for the treatment …
ADHD coach and breathwork experts to run workshop for ADHD management
April 2, 2025Design & Creative, Freelancers ADHD, Neurology, healthcare, mental health, nervous system
ADHD coach John Harrington and breathwork facilitator Martin O’Toole will collaborate on ‘Breathwork for ADHD and Beyond’, a breathwork-orientated session …
Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial
April 1, 2025Research and Development Cardiology, Novo Nordisk, cardiometabolic diseases, research and development
Novo Nordisk announced results from its SOUL cardiovascular outcomes trial. Rybelsus (oral semaglutide) significantly reduced the risk of major adverse …
Corcept’s relacorilant trial in patients with platinum-resistant ovarian cancer meets primary endpoint
April 1, 2025Research and Development Corcept Therapeutics, Oncology, ovarian cancer, research and development
Corcept Therapeutics announced that relacorilant plus nab-paclitaxel met its primary endpoint of improved progression-free survival in ROSELLA, the company’s phase …
Secarna Pharmaceuticals to announce positive new data at cancer research conference
April 1, 2025Research and Development Oncology, Secarna Pharmaceuticals, oncology, research and development
Secarna Pharmaceuticals will present new preclinical data with its lead programme SECN-15 at the American Association for Cancer Research (AACR) …
Qfitlia approved by FDA to treat haemophilia A or B
March 31, 2025Research and Development FDA, Haematology, Sanofi, haemophilia, pharma
The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran) as the first therapy in the US to treat …
Alfred Merz appointed as CEO of ProBioGen
March 31, 2025Manufacturing Services, Manufacturing and Production CEO, Pharmacy, ProBioGen, appointment, biotech
ProBioGen has announced the appointment of Alfred Merz as its chief executive officer (CEO), effective 1 April 2025. Merz, who …
Medidata launches programme to accelerate therapy delivery
March 31, 2025Market Research Medidata, Pharmacy, pharma, technology
Medidata has announced the launch of its Medidata Site Insights Program – a collection of initiatives intended to foster more …
Winners announced for 2025 PM Society Awards
March 31, 2025Industry Associations, Research and Development Pharmacy, awards, pharma industry, pm society
The pharma marketing and healthcare communications industry gathered for the 39th PM Society Awards on 14 March 2025, which celebrates …
FDA grants fast track designation to chlamydia vaccine candidate
March 28, 2025Research and Development FDA, Infections and infestations, Sanofi, chlamydia, vaccination
The US Food and Drug Association (FDA) has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention …
Shane Olwill appointed as chief development officer at Asgard Therapeutics
March 28, 2025Business Services, Clinical Research Asgard Therapeutics, CDO, Oncology, appointment, immunology
Asgard Therapeutics has announced the appointment of Shane Olwill as chief development officer (CDO). The biotech company develops in vivo …
Gergely Sved appointed as CEO of Ellab
March 28, 2025Contract Sales Organisations, Sales and Marketing CEO, Ellab, Pharmacy, appointment, life sciences
Ellab has announced that it has appointed Gergely Sved as its new chief executive officer (CEO). The company provides validation, …
Carole Imbert appointed as CFO of Vect-Horus
March 28, 2025Biotech/start-up, Sales and Marketing Pharmacy, Vect-Horus, appointment, biotech, cfo
Vect-Horus has announced it has appointed Carole Imbert as chief financial officer (CFO) and to its executive committee. Vect-Horus is …
Five of EU-27 account for 68% of pharma trade, report finds
March 27, 2025Market Research Logista Freight, Pharmacy, european union, market report, trade
Logista Freight has found that Germany, France, Belgium, Italy and the Netherlands account for up to 68% of trade in …
Pierre Fabre announces investments and partnerships in lung cancer research
March 27, 2025Research and Development Oncology, Pierre Fabre Laboratories, lung cancer treatment, oncology
Pierre Fabre Laboratories has announced investment and partnership plans to improve the lives of lung cancer patients with unmet needs. …
Allegro shares promising preclinical results for osteoarthritis treatment
March 26, 2025Clinical Trial Services, Research and Development Allegro, Orthopaedics, biomedical, clinical studies, osteoarthritis
Allegro has announced that hydrocelin, its injectable microparticle hydrogel, showed no signs of toxicity in two preclinical studies. Allegro is …
Pharming Group doses first patient in phase 2 trial of leniolisib in CVID
March 26, 2025Clinical Trial Services, Research and Development CVID, Immunology, Pharming Group, clinical trial, common variable immunodeficiency, immunodeficiency
Pharming Group has announced that the first patient has been dosed in a phase 2 clinical trial evaluating leniolisib in …
Cold Chain Technologies acquires Global Cold Chain Solutions
March 26, 2025Dedicated cold-chain delivery, Manufacturing and Production Global Cold Chain Solutions, Pharmacy, business development, cold chain, life sciences, partnership
Cold Chain Technologies (CCT), a global provider for temperature-sensitive packing and digital solutions, has acquired Global Cold Chain Solutions (GCCS), …
Gary Lyons appointed as EVP medical affairs of Coronado Research
March 26, 2025Business Services, Consultancy Consultancy, Coronado Research, Medical Affairs, Pharmacy, appointment
Coronado Research, a UK-based consultancy-led organisation, has announced that it has appointed Gary Lyons as executive vice president (EVP) for …
Latest content
FibroFind appoints Lee Borthwick as CEO
